等待開盤 12-20 09:30:00 美东时间
+0.550
+0.17%
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从22美元升至22.5美元;HC Wainwright & Co.:维持Climb Bio"买入"评级,目标价从9美元升至11美元
12-19 10:15
Truist Securities analyst Richard Newitter maintains Penumbra (NYSE:PEN) with a Buy and raises the price target from $312 to $370.
12-18 23:55
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
12-18 10:54
今日重点评级关注:HC Wainwright & Co.:维持Moleculin Biotech"买入"评级,目标价从4美元升至22美元;HC Wainwright & Co.:上调Soluna Holdings评级至"买入",目标价5美元
12-12 10:24
Issuing a largely positive outlook on the MedTech sector for 2026, Citi on Thursday upgraded Penumbra (PEN) and Bausch + Lomb (BLCO) on product launches but downgraded Intuitive Surgical (ISRG) and Ha...
12-12 03:05
Citigroup analyst Joanne Wuensch upgrades Penumbra (NYSE:PEN) from Neutral to Buy and raises the price target from $285 to $350.
12-11 22:03
Penumbra (NYSE:PEN) has outperformed the market over the past 10 years by 6.66%...
11-26 04:15
Penumbra (NYSE:PEN) has outperformed the market over the past 10 years by 6.31%...
11-12 00:15
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价;Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
U.S. stocks were lower, with the Dow Jones index falling more than 400 points o...
11-07 01:42